215 related articles for article (PubMed ID: 18822372)
1. Controlling cell surface dynamics and signaling: how CD82/KAI1 suppresses metastasis.
Miranti CK
Cell Signal; 2009 Feb; 21(2):196-211. PubMed ID: 18822372
[TBL] [Abstract][Full Text] [Related]
2. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.
Tsai YC; Weissman AM
FEBS Lett; 2011 Oct; 585(20):3166-73. PubMed ID: 21875585
[TBL] [Abstract][Full Text] [Related]
4. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
[TBL] [Abstract][Full Text] [Related]
5. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
Sridhar SC; Miranti CK
Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
[TBL] [Abstract][Full Text] [Related]
6. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression.
Bandyopadhyay S; Zhan R; Chaudhuri A; Watabe M; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Pauza ME; Hayashi S; Wang Y; Mohinta S; Mashimo T; Iiizumi M; Furuta E; Watabe K
Nat Med; 2006 Aug; 12(8):933-8. PubMed ID: 16862154
[TBL] [Abstract][Full Text] [Related]
7. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.
Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA
Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362
[TBL] [Abstract][Full Text] [Related]
8. Tetraspanin CD82 inhibits protrusion and retraction in cell movement by attenuating the plasma membrane-dependent actin organization.
Liu WM; Zhang F; Moshiach S; Zhou B; Huang C; Srinivasan K; Khurana S; Zheng Y; Lahti JM; Zhang XA
PLoS One; 2012; 7(12):e51797. PubMed ID: 23251627
[TBL] [Abstract][Full Text] [Related]
9. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
Malik FA; Sanders AJ; Jiang WG
Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
[TBL] [Abstract][Full Text] [Related]
11. Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration.
Takahashi M; Sugiura T; Abe M; Ishii K; Shirasuna K
Int J Cancer; 2007 Nov; 121(9):1919-1929. PubMed ID: 17621632
[TBL] [Abstract][Full Text] [Related]
12. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
13. A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling.
Li W; Hu M; Wang C; Lu H; Chen F; Xu J; Shang Y; Wang F; Qin J; Yan Q; Krueger BJ; Renne R; Gao SJ; Lu C
Oncogene; 2017 Sep; 36(38):5407-5420. PubMed ID: 28534512
[TBL] [Abstract][Full Text] [Related]
14. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj SN
J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
[TBL] [Abstract][Full Text] [Related]
15. Regulation of urokinase receptor proteolytic function by the tetraspanin CD82.
Bass R; Werner F; Odintsova E; Sugiura T; Berditchevski F; Ellis V
J Biol Chem; 2005 Apr; 280(15):14811-8. PubMed ID: 15677461
[TBL] [Abstract][Full Text] [Related]
16. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
17. Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.
Odintsova E; van Niel G; Conjeaud H; Raposo G; Iwamoto R; Mekada E; Berditchevski F
J Biol Chem; 2013 Sep; 288(36):26323-26334. PubMed ID: 23897813
[TBL] [Abstract][Full Text] [Related]
18. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
[TBL] [Abstract][Full Text] [Related]
19. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
20. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
